![The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment | npj Breast Cancer The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00276-y/MediaObjects/41523_2021_276_Fig1_HTML.png)
The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment | npj Breast Cancer
![Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2021/jco.2021.39.issue-6/jco.20.02063/20210209/images/large/jco.20.02063t4.jpeg)
Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer | Journal of Clinical Oncology
![Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy](https://www.mdpi.com/cancers/cancers-14-03848/article_deploy/html/images/cancers-14-03848-g001.png)
Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy
![A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-61535-9/MediaObjects/41598_2020_61535_Fig1_HTML.png)
A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports
![A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - The Breast A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - The Breast](https://www.thebreastonline.com/cms/asset/b4c9d307-60a2-407a-b21d-bf17e5c213f5/gr1.jpg)